{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:21:37Z","timestamp":1792790497241,"version":"4.5.0"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,1,15]]},"DOI":"10.2169\/internalmedicine.3591-24","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T22:12:48Z","timestamp":1717020768000},"page":"209-215","source":"Crossref","is-referenced-by-count":8,"title":["Immunoglobulin G4-related Autoimmune Pancreatitis and Hypopituitarism Following Immune Checkpoint Inhibitor Therapy"],"prefix":"10.2169","volume":"64","author":[{"given":"Saori","family":"Inoue","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Meitetsu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Tsunoda","sequence":"additional","affiliation":[{"name":"Department of Urology, Meitetsu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Meitetsu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Meitetsu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344: 732-738, 2001.","DOI":"10.1056\/NEJM200103083441005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 366: 539-551, 2012.","DOI":"10.1056\/NEJMra1104650"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Shimosegawa T, Chari ST, Frulloni L, et al.; International Association of Pancreatology. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40: 352-358, 2011.","DOI":"10.1097\/MPA.0b013e3182142fd2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hu YB, Zhang Q, Li HJ, et al.; the AME Academic Lung Cancer Cooperation Group. Evaluation of rare but severe immune related adverse effects in PD-1 and PD-L1 inhibitors in non-small cell lung cancer: a meta-analysis. Transl Lung Cancer Res 6: 8-20, 2017.","DOI":"10.21037\/tlcr.2017.12.10"},{"key":"5","unstructured":"5. Choueiri TK, Tomczak P, Park SH, et al.; the KEYNOTE-564 Investigators. Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma. N Engl J Med 385: 683-694, 2021."},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Hana C, Rehman T, Park K, et al. Pancreatic adverse events in patients treated with immune checkpoint inhibitors. JGH Open 7: 204-207, 2023.","DOI":"10.1002\/jgh3.12875"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sasaki T, Yajima T, Shimaoka T, et al. Synergistic effect of IgG4 antibody and CTLs causes tissue inflammation in IgG4-related disease. Int Immunol 32: 163-174, 2020.","DOI":"10.1093\/intimm\/dxz073"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Michot JM, Bigenwald C, Champiat S, et al. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer 54: 139-148, 2016.","DOI":"10.1016\/j.ejca.2015.11.016"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wallace ZS, Naden RP, Chari S, et al.; the American College of Rheumatology\/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group. The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol 72: 7-19, 2020.","DOI":"10.1002\/art.41120"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kawa S, Kamisawa T, Notohara K, et al. Japanese Clinical Diagnostic Criteria for Autoimmune Pancreatitis, 2018: Revision of Japanese Clinical Diagnostic Criteria for Autoimmune Pancreatitis, 2011. Pancreas 49: 13-14, 2020.","DOI":"10.1097\/MPA.0000000000001443"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Champion B, Chai SM, Bhandari M, Gunawardena D. IgG4-related autoimmune pancreatitis-like mass-forming lesion on a background of immune checkpoint inhibitor immunotherapy. Pathology 55: 133-136, 2023.","DOI":"10.1016\/j.pathol.2022.04.010"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Agrawal R, Guzman G, Karimi S, et al. Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis following the administration of nivolumab: a case report. World J Clin Cases 10: 7124-7129, 2020.","DOI":"10.12998\/wjcc.v10.i20.7124"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rogers BB, Cuddahy T, Zawislak C. Management of acute pancreatitis associated with checkpoint inhibitors. J Adv Pract Oncol 11: 49-62, 2020.","DOI":"10.6004\/jadpro.2020.11.1.3"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Shikuma J, Kan K, Ito R, et al. Critical review of IgG4-related hypophysitis. Pituitary 20: 282-291, 2017.","DOI":"10.1007\/s11102-016-0773-7"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Amereller F, Deutschbein T, Joshi M, et al. Differences between immunotherapy-induced and primary hypophysitis - a multicenter retrospective study. Pituitary 25: 152-158, 2022.","DOI":"10.1007\/s11102-021-01182-z"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Li Y, Gao H, Li Z, Zhang X, Ding Y, Li F. Clinical characteristics of 76 patients with IgG4-related hypophysitis: a systematic literature review. Int J Endocrinol 2019: 5382640, 2019.","DOI":"10.1155\/2019\/5382640"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Iseda I, Hida K, Tone A, et al. Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis. Endocr J 61: 195-203, 2014.","DOI":"10.1507\/endocrj.EJ13-0407"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/2\/64_3591-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T03:29:23Z","timestamp":1737170963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/2\/64_3591-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3591-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"article-number":"3591-24"}}